Chemours price target lowered to $22 from $27 at Truist

Truist lowered the firm’s price target on Chemours (CC) to $22 from $27 and keeps a Buy rating on the shares as part of a broader research note on Chemicals. Given the unfolding “tariff saga”, the firm has updated its models, and while the new estimates do not assume a significant recession, they do incorporate more limited expectations for underlying demand growth in 2025-2026, the analyst tells investors in a research note.